Genetic Variants in the Host Restriction Factor APOBEC3G are Associated With HIV-1–Related Disease Progression and Central Nervous System Impairment in Children

od Singh, Kumud K., Wang, Yan, Gray, Kathryn P., Farhad, Mona, Brummel, Sean, Fenton, Terence, Trout, Rodney, Spector, Stephen A.
Wydane 2013

Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmen...

od Buechler, Steven A, Gray, Kathryn P, Gökmen-Polar, Yesim, Willis, Scooter, Thürlimann, Beat, Kammler, Rosita, Viale, Giuseppe, Leyland-Jones, Brian, Badve, Sunil S, Regan, Meredith M
Wydane w JNCI Cancer Spectr (2019)

Impact of New Systemic Therapies on Overall Survival of Patients with Metastatic Castration Resistant Prostate Cancer in a Hospital-based Registry

od Francini, Edoardo, Gray, Kathryn P., Shaw, Grace K., Evan, Carolyn P., Hamid, Anis A., Perry, Caitlin E., Kantoff, Philip W., Taplin, Mary-Ellen, Sweeney, Christopher J.
Wydane w Prostate Cancer Prostatic Dis (2019)

Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib

od Eismann, Julia, Heng, Yujing J., Waldschmidt, Johannes M., Vlachos, Ioannis S., Gray, Kathryn P., Matulonis, Ursula A., Konstantinopoulos, Panagiotis A., Murphy, Charles J., Nabavi, Sheida, Wulf, Gerburg M.
Wydane w J Cancer Res Clin Oncol (2019)

Time of Metastatic Disease Presentation and Volume of Disease are Prognostic for Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

od Francini, Edoardo, Gray, Kathryn P., Xie, Wanling, Shaw, Grace K., Valença, Loana, Bernard, Brandon, Albiges, Laurence, Harshman, Lauren C., Kantoff, Philip W., Taplin, Mary-Ellen, Sweeney, Cristopher J.
Wydane w Prostate (2018)

Radium-223 dichloride in Combination with Vascular Endothelial Growth Factor-Targeting Therapy in Advanced Renal Cell Carcinoma with Bone Metastases

od McKay, Rana R., Bossé, Dominick, Gray, Kathryn P., Michaelson, M. Dror, Krajewski, Katherine, Jacene, Heather A., Walsh, Meghara, Bellmunt, Joaquim, Pomerantz, Mark, Harshman, Lauren C., Choueiri, Toni K.
Wydane w Clin Cancer Res (2018)

A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration-resistant prostate cancer

od Choudhury, Atish D., Gray, Kathryn P., Supko, Jeffrey G., Harshman, Lauren C., Taplin, Mary-Ellen, Pace, Amanda Fredericks, Farina, Matthew, Zukotynski, Katherine A., Bernard, Brandon, Kantoff, Philip W., Pomerantz, Mark, Sweeney, Christopher
Wydane w Prostate (2018)

Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma

od de Velasco, Guillermo, Gray, Kathryn P., Hamieh, Lana, Urun, Yuksel, Carol, Hallie A., Fay, Andre P., Signoretti, Sabina, Kwiatkowski, David J., McDermott, David F., Freedman, Matthew, Pomerantz, Mark M., Choueiri, Toni K.
Wydane w Eur Urol Focus (2016)

Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial

od Liu, Joyce F., Herold, Christina, Gray, Kathryn P., Penson, Richard T., Horowitz, Neil, Konstantinopoulos, Panagiotis A., Castro, Cesar M., Hill, Sarah J., Curtis, Jennifer, Luo, Weixiu, Matulonis, Ursula A., Cannistra, Stephen A., Dizon, Don S.
Wydane w JAMA Oncol (2019)

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-0...

od Pruneri, Giancarlo, Gray, Kathryn P., Vingiani, Andrea, Viale, Giuseppe, Curigliano, Giuseppe, Criscitiello, Carmen, Láng, István, Ruhstaller, Thomas, Gianni, Lorenzo, Goldhirsch, Aron, Kammler, Roswitha, Price, Karen N., Cancello, Giuseppe, Munzone, Elisabetta, Gelber, Richard D., Regan, Meredith M., Colleoni, Marco
Wydane w Breast Cancer Res Treat (2016)

Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression

od Lalani, Aly-Khan A., Gray, Kathryn P., Albiges, Laurence, Callea, Marcella, Pignon, Jean-Christophe, Pal, Soumitro, Gupta, Mamta, Bhatt, Rupal S., McDermott, David F., Atkins, Michael B., Woude, G.F. Vande, Harshman, Lauren C., Choueiri, Toni K., Signoretti, Sabina
Wydane w Oncotarget (2017)

Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-Resistant Prostate Cancer: A Phase 1 Study of Concurrent Enzalutamide and Crizotinib

od Tripathi, Abhishek, Supko, Jeffrey G., Gray, Kathryn P., Melnick, Zachary J., Regan, Meredith, Taplin, Mary-Ellen, Choudhury, Atish D., Pomerantz, Mark M., Bellmunt, Joaquim, Yu, Channing, Sun, Zijie, Srinivas, Sandy, Kantoff, Philip W., Sweeney, Christopher J., Harshman, Lauren C.
Wydane w Clin Cancer Res (2020)

Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial

od Ewertz, Marianne, Gray, Kathryn P., Regan, Meredith M., Ejlertsen, Bent, Price, Karen N., Thürlimann, Beat, Bonnefoi, Hervé, Forbes, John F., Paridaens, Robert J., Rabaglio, Manuela, Gelber, Richard D., Colleoni, Marco, Láng, István, Smith, Ian E., Coates, Alan S., Goldhirsch, Aron, Mouridsen, Henning T.
Wydane 2012

Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers

od Sieuwerts, Anieta M., Willis, Scooter, Burns, Michael B., Look, Maxime P., Gelder, Marion E. Meijer-Van, Schlicker, Andreas, Heideman, Marinus R., Jacobs, Heinz, Wessels, Lodewyk, Leyland-Jones, Brian, Gray, Kathryn P., Foekens, John A., Harris, Reuben S., Martens, John W. M.
Wydane w Horm Cancer (2014)

Prospective Analysis of Genetic Polymorphisms and Risk of Recurrence in Renal Cell Cancer

od Schutz, Fabio A. B., Pomerantz, Mark M., Gray, Kathryn P., Atkins, Prof Michael B., Rosenberg, Jonathan E., Hirsch, Michelle S., McDermott, David F., Lampron, Megan E., Lee, Gwo-Shu Mary, Signoretti, Sabina, Kantoff, Prof Philip W., Freedman, Matthew L., Choueiri, Toni K.
Wydane 2012

Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial

od Johansson, Harriet, Gray, Kathryn P., Pagani, Olivia, Regan, Meredith M., Viale, Giuseppe, Aristarco, Valentina, Macis, Debora, Puccio, Antonella, Roux, Susanne, Maibach, Rudolf, Colleoni, Marco, Rabaglio, Manuela, Price, Karen N., Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron, Kammler, Roswitha, Bonanni, Bernardo, Walley, Barbara A.
Wydane w Breast Cancer Res (2016)

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: the CASA randomized...

od Crivellari, Diana, Gray, Kathryn P, Dellapasqua, Silvia, Puglisi, Fabio, Ribi, Karin, Price, Karen N, Láng, István, Gianni, Lorenzo, Spazzapan, Simon, Pinotti, Graziella, Lüthi, Jean-Marc, Gelber, Richard D, Regan, Meredith M, Colleoni, Marco, Castiglione-Gertsch, Monica, Maibach, Rudolf, Rabaglio, Manuela, Coates, Alan S, Goldhirsch, Aron
Wydane 2013

Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor–Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of O...

od Bellet, Meritxell, Gray, Kathryn P., Francis, Prudence A., Láng, István, Ciruelos, Eva, Lluch, Ana, Climent, Miguel Angel, Catalán, Gustavo, Avella, Antoni, Bohn, Uriel, González-Martin, Antonio, Ferrer, Roser, Catalán, Roberto, Azaro, Analía, Rajasekaran, Agnita, Morales, Josefa, Vázquez, Josep, Fleming, Gini F., Price, Karen N., Regan, Meredith M.
Wydane w J Clin Oncol (2016)

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

od Colleoni, Marco, Gray, Kathryn P., Gelber, Shari, Láng, István, Thürlimann, Beat, Gianni, Lorenzo, Abdi, Ehtesham A., Gomez, Henry L., Linderholm, Barbro K., Puglisi, Fabio, Tondini, Carlo, Kralidis, Elena, Eniu, Alexandru, Cagossi, Katia, Rauch, Daniel, Chirgwin, Jacquie, Gelber, Richard D., Regan, Meredith M., Coates, Alan S., Price, Karen N., Viale, Giuseppe, Goldhirsch, Aron
Wydane w J Clin Oncol (2016)

High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers

od Willis, Scooter, Sun, Yuliang, Abramovitz, Mark, Fei, Teng, Young, Brandon, Lin, Xiaoqian, Ni, Min, Achua, Justin, Regan, Meredith M., Gray, Kathryn P., Gray, Robert, Wang, Victoria, Long, Bradley, Kammler, Roswitha, Sparano, Joseph A., Williams, Casey, Goldstein, Lori J., Salgado, Roberto, Loi, Sherene, Pruneri, Giancarlo, Viale, Giuseppe, Brown, Myles, Leyland-Jones, Brian
Wydane w JCO Precis Oncol (2017)